ANI Pharmaceuticals, Inc. (ANIP)
71.47
+0.41
(+0.58%)
USD |
NASDAQ |
Nov 13, 16:00
71.47
0.00 (0.00%)
After-Hours: 19:59
ANI Pharmaceuticals Market Cap : 1.637B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 1.627B |
| November 11, 2026 | 1.628B |
| November 10, 2026 | 1.632B |
| November 09, 2026 | 1.552B |
| November 06, 2026 | 1.544B |
| November 05, 2026 | 1.594B |
| November 04, 2026 | 1.641B |
| November 03, 2026 | 1.655B |
| November 02, 2026 | 1.623B |
| October 30, 2026 | 1.654B |
| October 29, 2026 | 1.681B |
| October 28, 2026 | 1.647B |
| October 27, 2026 | 1.635B |
| October 26, 2026 | 1.668B |
| October 23, 2026 | 1.668B |
| October 22, 2026 | 1.694B |
| October 21, 2026 | 1.660B |
| October 20, 2026 | 1.669B |
| October 19, 2026 | 1.667B |
| October 16, 2026 | 1.661B |
| October 15, 2026 | 1.660B |
| October 14, 2026 | 1.612B |
| October 13, 2026 | 1.627B |
| October 12, 2026 | 1.691B |
| October 09, 2026 | 1.697B |
| Date | Value |
|---|---|
| October 08, 2026 | 1.654B |
| October 07, 2026 | 1.652B |
| October 06, 2026 | 1.643B |
| October 05, 2026 | 1.667B |
| October 02, 2026 | 1.658B |
| October 01, 2026 | 1.676B |
| September 30, 2026 | 1.669B |
| September 29, 2026 | 1.668B |
| September 28, 2026 | 1.719B |
| September 25, 2026 | 1.700B |
| September 24, 2026 | 1.701B |
| September 23, 2026 | 1.710B |
| September 22, 2026 | 1.790B |
| September 21, 2026 | 1.811B |
| September 18, 2026 | 1.749B |
| September 17, 2026 | 1.732B |
| September 16, 2026 | 1.691B |
| September 15, 2026 | 1.657B |
| September 14, 2026 | 1.617B |
| September 11, 2026 | 1.612B |
| September 10, 2026 | 1.642B |
| September 09, 2026 | 1.624B |
| September 08, 2026 | 1.613B |
| September 04, 2026 | 1.636B |
| September 03, 2026 | 1.654B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 1.360T |
| Supernus Pharmaceuticals, Inc. | 1.730B |
| Ocular Therapeutix, Inc. | 1.364B |
| Corcept Therapeutics, Inc. | 7.979B |
| Veru, Inc. | 36.15M |
Market Cap Related Metrics
| PE Ratio | 14.27 |
| PS Ratio | 1.491 |
| PEG Ratio | 0.0689 |
| Price to Book Value | 2.569 |
| Price to Free Cash Flow | 7.767 |
| Price | 71.47 |
| Earnings Yield | 7.01% |
| PEGY Ratio | 0.0689 |
| Operating PE Ratio | 9.735 |
| Normalized PE Ratio | 15.66 |